---
title: "Polaryx 的股票在公司宣佈選擇一家合同研究組織進行 SOTERIA 項目，以評估 PLX-200 在四種不同的 LSDs 中的應用後，交易價格上漲"
description: "Polaryx 的股票在公司宣佈選擇一家合同研究組織進行 SOTERIA 項目，以評估 PLX-200 在四種不同的 LSDs 中的應用後，交易價格上漲"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/276149945.md"
published_at: "2026-02-17T16:52:22.000Z"
---

# Polaryx 的股票在公司宣佈選擇一家合同研究組織進行 SOTERIA 項目，以評估 PLX-200 在四種不同的 LSDs 中的應用後，交易價格上漲

Polaryx 的股票在公司宣佈選擇了一家合同研究組織來評估 PLX-200 在四種不同的 LSD 中的應用後，交易價格上漲。

### Related Stocks

- [PLYX.US - Polaryx Therapeutics](https://longbridge.com/zh-HK/quote/PLYX.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Small Cap Polaryx Picks Research Partner, Stock Surges on Phase 2 Trial Plans | Polaryx Therapeutics (NASDAQ: PLYX) shares surged 46.06% to $3.52 following the selection of a research organization for | [Link](https://longbridge.com/zh-HK/news/276143893.md) |
| Polaryx Therapeutics Announces SOTERIA Trial Launch for PLX-200 in Krabbe Disease | Polaryx Therapeutics Inc. has announced the launch of the SOTERIA trial to evaluate PLX-200, a therapy for Krabbe diseas | [Link](https://longbridge.com/zh-HK/news/275466866.md) |
| Waste Connections' Softer-Than-Expected 2026 Free Cash Flow Outlook Draws Focus, RBC Says | Waste Connections' Softer-Than-Expected 2026 Free Cash Flow Outlook Draws Focus, RBC Says | [Link](https://longbridge.com/zh-HK/news/276147413.md) |
| Goldman Warns Stock Buybacks In Jeopardy Due To Soaring Hyperscaler CapEx | Two weeks ago, when the Mag 7 stocks stunned markets with their drastically revised 2026 capex guidance, which soared by | [Link](https://longbridge.com/zh-HK/news/276075843.md) |
| Is CNO Financial Group (CNO) Pricing Reflect Its Mixed Valuation Signals? | CNO Financial Group's current share price of $43.06 suggests mixed valuation signals. The stock has shown returns of 0.0 | [Link](https://longbridge.com/zh-HK/news/276114927.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。